Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, on January 4 issued a statement, updating the continued efforts to mitigate the IV saline and amino acids for injection shortages caused by Hurricane Maria.
The FDA expects the IV saline shortage to improve in early 2018. Just before the holidays, Baxter announced that all of their facilities on the island had returned to the commercial power grid. All other manufactures that were on the FDA’s initial list at risk for shortages also are now on the power grid. However, the commercial power grid remains unstable in places.
The return of power to all of Baxter’s facilities also means the shortage of pediatric and adult formulations of IV amino acids will continue to improve in the coming weeks.